Middle income vs Naoero: Immunization, Hib3
Middle income
77.1%
in 2024
Naoero
97.0%
in 2024
Middle income rank
26th
Naoero rank
29th
Immunization, Hib3 over time
- Middle income
- Naoero
How they compare
Naoero currently reports 97.0% against 77.1% in Middle income, a difference of 19.9%.
That makes Naoero's figure about 1.3 times Middle income's.
Across all 16 years both countries report, Naoero has been ahead every year.
Middle income ranks 26th and Naoero ranks 29th of 43 groups.
Naoero has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Middle income | Naoero | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 28.5% | 99.0% | 70.5% | Naoero |
| 2010s | 52.3% | 92.0% | 39.7% | Naoero |
| 2020s | 73.4% | 96.8% | 23.4% | Naoero |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Middle income or Naoero?
- Naoero, at 97.0% against 77.1% in Middle income as of 2024.
- What is the difference in immunization, hib3 between Middle income and Naoero?
- 19.9%, with Naoero ahead.
- How many years of comparable data are there for Middle income and Naoero?
- 16 years are reported by both, from 2009 to 2024.
- How do Middle income and Naoero rank globally for immunization, hib3?
- Middle income ranks 26th and Naoero ranks 29th of 43 groups.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.